Clinical update: new treatments for age-related macular degeneration
Authors:
- 1 July 2007
- journal article
- Published by Elsevier in The Lancet
- Vol. 370 (9583) , 204-206
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Visual Impairment, Age-Related Macular Degeneration, Cataract, and Long-term MortalityArchives of Ophthalmology (1950), 2007
- Age-Related Macular Degeneration Is Associated with Incident Myocardial Infarction among Elderly AmericansOphthalmology, 2007
- Age-Related Macular Degeneration and Risk of Coronary Heart DiseaseOphthalmology, 2007
- The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBritish Journal of Ophthalmology, 2006
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Evolving European guidance on the medical management of neovascular age related macular degenerationBritish Journal of Ophthalmology, 2006
- Intravitreal Avastin: The Low Cost Alternative to Lucentis?American Journal of Ophthalmology, 2006
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- The epidemiology of age-related macular degenerationAmerican Journal of Ophthalmology, 2004